Initial testing (stage 1) of the anti‐microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program

Publisher: John Wiley & Sons Inc

E-ISSN: 1545-5017|1545-5009|11|1897-1905

ISSN: 1545-5009

Source: PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.1545-5009, Iss.11, 2015-11, pp. : 1897-1905

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract